AUDIT OF SELECTED BIOTECHNOLOGY DEVELOPMENT FIRMS THAT ARE STAKEHOLDERS IN HYPERLIPIDEMIA/ATHEROSCLEROSIS AND OTHER CARDIOVASCULAR INDICATIONS
ACTELION
ALEXION
AVANT
AXYS
BIOPROJET
BIO-TECHNOLOGY GENERAL
BIOGEN
CELL GENESYS
CELLTECH GROUP
CENTOCOR
CHIRON
COR THERAPEUTICS
CORIXA
CORVAS
CV THERAPEUTICS
DAIICHI SEIYAKU
EMISPHERE TECHNOLOGIES
ENTREMED
ESPERION THERAPEUTICS
GELTEX PHARMACEUTICALS
GENENTECH
GILEAD SCIENCES
GUILFORD
HUMAN GENOME SCIENCES
IMMUNEX
INCARA (INTERNEURON)
LIGAND PHARMACEUTICAL
MEDIGENE
MILLENNIUM PHARMACEUTICALS
MITSUI
NITROMED
PIERRE FABRE
PROTEIN DESIGN LABS
PROTEUS
SCIOS
TEXAS BIOTECHNOLOGY
TRIGEN
VASCULAR GENETICS
VICAL